Princeton Washington DC Mexico Bogota Rio de Janeiro Basel Johannesburg Riyadh Hong Kong

KYBORACompany BackgroundMay 2015

2 I

COM

PANY O

VERVIEW

Kybora is a global advisory firm focused on mergers and acquisitions, licensing, and commercialization of pharmaceutical products and medical devices. We distinguish ourselves by:

• Our global reach – We have offices in the US, Mexico, Brazil, Switzerland, Saudi Arabia, South Africa , and China. In addition, we have established strong partnerships Japan, Russia, and India, giving us access to strategic and financial investors located all over the world .

• The experience of our team – Our team combines over 300 years of business development experience in emerging markets. All of us have held senior level operational roles in the pharmaceutical and medical devices industries. We bring a unique perspective to our clients by understanding the operational challenges to being successful in emerging markets. Our worldwide network of relationships is unparalleled. We have access to decision makers which facilitates and accelerates transactions.

• Our areas of focus – We focus exclusively on life sciences transactions. We have had great success helping companies located in emerging markets sell themselves to strategic and financial investors located all over the world. We also help healthcare companies (Pharma, Biotech, Devices) maximize the value of their assets on a global basis through optimal licensing deals.

• Our engagement model - We pride ourselves for being honest, hard working, resilient, and dedicated to our clients. We seek to establish long-term relationships with our clients. Our engagement model is flexible and collaborative, providing our clients with a customized approach and intimate understanding of the pharma/biotech/medical devices decision-making process on a global scale.

We believe in the globalization of the healthcare market and in our ability to help our clients benefit in this evolving market landscape. We welcome the opportunity to work with you on your strategic needs.

3 I

GLO

BAL COVERAG

E

KYBORA - a company with global coverage:

KYBORA has offices in Princeton, Washington DC, Mexico City, Bogota, Rio de Janeiro, Basel, Johannesburg, Riyadh, and Hong Kong

In addition, KYBORA leverages well-established partnerships in Japan, India, Brazil, and Chile to provides its clients access to financial and strategic investors on a global basis

KYBORA offers the best combination of global reach and local knowledge.

JapanPartnered withDr. Newzella

IndiaPartnered withSathguru International

Basel

Princeton

Mexico City

Rio de Janeiro

Johannesburg

Hong KongRiyadh

Washington DC

Partnership with Biominas in Brazil

Partnership with Euro America in Chile

Bogota

4 I

COM

PANY O

VERVIEWOur Team

Alan Vanderborght, MBAManaging Director and CEO

18+ years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol- Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

Dr. Ernesto Neumaan, MBA, Ph.D. Managing Director Latin America

40 + years career with Merck KGaA in Latam. General Manager in Argentina, Brazil, Ecuador, Colombia, Mexico, Peru, and regional VP Latam Merck Serono which had sales of $1.3 B and 2800 employees. During his tenure at Merck, Dr. Neumann realized more than 10 transactions. Merck Serono has the largest sales share in Latam of all multinational companies.

Nicolas Gikakis,MBAManaging Director Medical Device

18+ years of experience in the medical device and biotech fields. Global leadership positions at Pall, Terumo, and DSCP/Maquet, managing $200M business. Involved in several distribution, licensing, and M&A deals including the acquisition of brands from J&J, licensing of assets to Medtronic and Terumo, and integration of assets into existing commercial operations. Previous clinical and research background.

Ulrich Steuer,MBAManaging Director Mexico

30+ years of experience in the pharmaceutical industry in Latam. General Manager for Bristol-Myers Squibb in Mexico and Argentina. Prior to that Ulrich was Vice President Latin America Marketing and Business Development for Aventis where he was responsible for the launch of Lantus® in the region as well as many other products. He also held the position of GM Venezuela for Aventis.

Dr. Stephen Lee, Ph.D.Managing Director Asia Pacific

15+ years of experience in the life sciences sector. 7 + years working in Hong Kong and Asia. Founded and worked for start-ups (CASiGEN Pharma, TianXing Biopharmaceutical, LifeQual Pharmaceuticals) Experience in consulting, business development, fund raising (Ventac Partners, Bio-Enabler, 3V SourceOne Capital, Applied Strategies), and in equity research (First State Investments), and patent law (USPTO).

5 I

COM

PANY O

VERVIEWOur Team

Dr. Khalid Alkharfy,Pharm D., Ph.D.Managing Director Middle East and Africa

12 + years experience in pharmaceutical consultation, management, research, and product development Headed the Research Department of region's fourth generation science park - Riyadh Techno Valley where he was responsible for managing R&D activities. Managing Director of a biotechnology incubator in Riyadh, Saudi Arabia

Michal Bartos,MBAManaging Director Europe

35 years of experience in the pharma industry including CIBA-GEIGY/Novartis and Merck KGaA. Country Manager Italy and Czech Republic, Regional VP Central/Eastern Europe and Global Head Commercial Operations BU Fertility and Endocrinology. Vast BD experience with transactions in Switzerland, Portugal, Denmark, Central and Eastern European markets and in the Near and Middle East.

Francisco Hidalgo

Managing Director Latin America

34+ years of experience in the pharmaceutical industry in Latam. General Manager of Brazil, Mexico, Puerto Rico, Caribbean Region, Colombia, Regional VP for Central and South America, and VP of Global Mature Product Portfolio, Geographic Optimization and Footprint, Tactical Divestitures and Distributor Markets Working Group for BMS. VP and COO of Procaps Group.

Dr. Juan Camilo Palacio, MD, MBAAdvisor Latin America

25 years of experience in the life sciences sector in Latin America. Held several commercial leadership positions including CEO of Biotoscana, CEO of Lafrancol, President AstraZeneca Andean countries, General Manager Sanofi Brazil. Extensive M&A experience including the acquisition of Boots Pharma, Deutsch Pharma, OTC portfolio, and United Medical, and the divestiture of Lafrancol to CFR

Benjamin Vicuña, MBAAdvisor Medical Devices

20+ years of global experience in sales and marketing management, new business development and general management in the US, Europe and Latam with multinational companies including Johnson & Johnson, Boston Scientific and Healthpoint Biotherapeutics. Most recently he was General Manager for Latin America for Molnlycke Healthcare.

6 I

COM

PANY O

VERVIEWOur Team

Maurício GrimoniAdvisor Medical Devices Latin America

25+ years of experience in Med Dev and pharma in Brazil and LatAm. Country and LatAm manager for MNC and regional firms such as Bristol Myers Squibb, Merck Serono, Novartis, Janssen and Becton Dickinson. Managed and developed distribution networks. Economist with a MBA from PUC-São Paulo. Founded Latina Health Solutions, a specialized consulting company in Life Sciences for Latin America.

BK SinhaAdvisor Medical Devices India Asia

25+ years of experience in Med Device in India, Asia -PAC, MENA. Developed and managed extensive distributor networks for hospital products. Int’l manager for MNCs and regional firms, including Philips Medical Systems, Datascope Corp, USA and Eurocor. Extensive travel and strong connections with companies and Clinicians in MENA, Far East and Asia.

Dr. Oye Olukotun,MD, MPH, FACCAdvisor US

30 years experience in the pharma industry. CEO of Epigen Pharma and Vice Chairman of Cardiovax Inc., a biotech company developing innovative cardiovascular therapies. Co-founder and CMO of VIA Pharmaceuticals, CEO of of CR Strategies, LLC, a clinical research and development consulting firm, VP of Regulatory Affairs and CMO of Mallinckrodt, Inc., Director of diaDexus, Inc, past- Director of BioClinica, Nordion, & SemBiosys Genetics Inc.

Dan LiftonMBAAdvisor US

15 + years of experience in the nutraceutical industry. CEO of Quality of Life Labs. Recipient of 3 Nutracon Award for Scientific Achievement. President of the “Patented and Branded Products” division at Maypro. Worked at Deutsche Bank, Citigroup and Draper Fisher Jurvetson Gotham Ventures. Recipient of the “Most Promising MBA Entrepreneur of the Year” Award from Forbes magazine. Member of the American Society of Anti-Aging Medicine.

John GreggMBA, CLPAdvisor US

25 years experience in the pharma industry. CEO of BalinBac Therapeutics. Past CEO of Symbiomix Therapeutics and LifeQual Pharmaceuticals. Executive Director of Commercial Operations for AkaRx. Team Leader, Global New Products / Market Analytics at Pfizer. Worked in Anti-infectives, Dermatology, and Oncology groups at BMS, J&J, and Novartis. He began his career as a microbiologist, protein biochemist, and molecular biologist.

7 I

COM

PANY O

VERVIEWOur Services

Mergers and Acquisitions

Target Identification Valuation Preparation of Offers Due Diligence Negotiations Transition and

Integration Financing

Product Licensing and Distribution

Licensing Strategy Asset Screening Asset Positioning Partner Identification Contract Drafting Negotiations Transition services

Global Commercialization

Deliver Commercial Success Beyond Licensing

Commercialize New Products Successfully

Maximize Revenue of Existing Brands

8 I

ENG

AGEM

ENT M

OD

ELOur Engagement Model

Definition of

acquisition, divestiture or licensing

strategy

Valuation of

asset’s global

potential

Identification and

screening of

potential partners

Preparation of

positioning

material

Outreach and

selection of lead

partner(s)

Negotiation of Terms

and deal execution

CommercialLaunc

h

Kybora’s engagement model is flexible and collaborative. It can be customized to meet your specific objectives. 

Our experienced resources will deliver immediate value to your organization at any point of the global merger, acquisition, divestiture, licensing, and commercialization spectrum.

We typically engage with a monthly retainer and a percentage of the consideration.

9 I

VALUE PRO

POSITIO

NKybora Value Proposition

Our team’s experience in the

global pharma and medical device

markets is unparalleled

No other boutique firm has the breadth

of our global coverage

We are a relationship based company. We pride ourselves on repeat business.

Each of our clients works with a

dedicated teamOur approach is

collaborative and adaptable to our

clients’ needs

We work directly with decision makers located all over the

world therefore facilitating and

accelerating the business

development process

10 I

CON

TACT INFO

RMATIO

NContact Us

PrincetonAlan Vanderborghtalan@torreya-EM.com

+1 609 970 4398

Rio de JaneiroDr. Ernesto Neumaanernesto@torreya-EM.com

+55 212 434 5286

Mexico CityUlrich Steuer

ulrich@torreya-EM.com+52-155-1384-6361

Hong KongDr. Stephen Lee

stephen@torreya-EM.com+852 6650 6402

Riyadh Dr. Khalid Alkharfy

khalid@torreya-EM.com+ 966 562-99179

Washington DCNicolas Gikakis

nicolas@torreya-EM.com+1 516 702 0651

Basel Michal Bartos

michal@torreya-EM.com+41 79 593 17 33